Beeson PB. Jaundice occurring one to four months after transfusion of blood or plasma: report of 7 cases. JAMA 1943; 21:1332.

https://doi.org/10.1001/jama.1943.02840170016005

Krugman S. lnfectious diseases of children. Mosby 1998:157-188.

Bonkovsky H, Mehta S. Hepatitis C: a review and update.J Am Acad Dermatol 2001;44:159-179.

https://doi.org/10.1067/mjd.2001.109311

Krugman S, Giles JP, Hammond J. Infectious hepatitis: evidence for two distinctive clinical, epidemiological, and immunological types of infection. JAMA 1967; 200:365-373.

https://doi.org/10.1001/jama.1967.03120180053006

Choo QL, Kuo G, Weiner AJ, et al. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 1989; 244:359-362.

https://doi.org/10.1126/science.2523562

Bukh J, Miller RH, Purcell RH. Genetic heterogeneity of hepatitis C virus: quasispecie and genotypes. Semin Liver Dis 1995; 15:41-63.

https://doi.org/10.1055/s-2007-1007262

Simmonds P, Alberti A, Alter HJ, et al. A proposed system for the nomenclature of hepatitis C viral genotypes. Hepatology 1994; 19:1321-1324.

https://doi.org/10.1002/hep.1840190538

Wu YY, Hsu TC, Chen TY, et al. Proteinase and dihydrolipoamide dehydrogenasa (E3) are major autoantigens in hepatitis C virus infection. Clin Exp Immunol 2002; 128:347-352.

https://doi.org/10.1046/j.1365-2249.2002.01827.x

Clifford BD ,Donahue D , Smith L , e t al. High prevalence of serologic markers of autoimmunity in patients with chronic hepatitis C. Hepatology 1995; 21:613-619.

https://doi.org/10.1002/hep.1840210302

Lauer GM, Walker BD. Hepatitis C infection. N Engl J Med 2001; 345:41-52.

https://doi.org/10.1056/NEJM200107053450107

Alter MJ, Kruszon-Moran D, Nainan OV, et al. The prevalence of hepatitis C virus infection in the United States, 1988 through 1994. N Engl J Med 1999; 341:556-562.

https://doi.org/10.1056/NEJM199908193410802

Echavarría E. Estudio de anticuerpos contra el virus de la hepatitis C en donantes y grupos de alto riesgo. Acta Med Colomb 1991; 17:11-15.

Buelvas AC, Mena M, López A.Prevalencia de anticuerpos contra el virus de la hepatitis C en donantes voluntarios de sangre. Colombia Med 1992; 23:21-23.

Hoyos A, Vanegas N, Páez E. Epidemiología de la hepatitis C en Colombia. Acta Med Colomb 2002; 27:209- 217.

Schreiber GB,Busch MP,Kleinman SH,et al.Therisk of transfusion-transmitted viral infections. N Engl J Med 1996; 334:1685-1690.

https://doi.org/10.1056/NEJM199606273342601

Legler TJ, Riggert J, Simson G, et al. Testing of individual blood donations for HCV RNA reduces the residual risk of transfusion-transmitted HCV infection. Transfusion 2000; 40:1192-1197.

https://doi.org/10.1046/j.1537-2995.2000.40101192.x

Katsoulidou A, Paraskevis D, Kalapothaki V, et al. Molecular epidemiology of a hepatitis C virus outbreak in a haemodialysis unit: Multicentre Haemodialysis Cohort Study on Viral Hepatitis. Nephrol Dial Transplant 1999; 14:1188-1194.

https://doi.org/10.1093/ndt/14.5.1188

Bronowicki JP,Venard V,Botte C,et al.Patient-to-patient transmission of hepatitis C virus during colonoscopy. N Engl J Med 1997; 337:237-240.

https://doi.org/10.1056/NEJM199707243370404

Esteban JI, Gómez J, Martell M, et al. Transmission of hepatitis C virus by a cardiac surgeon. N Engl J Med 1996; 334:555-558.

https://doi.org/10.1056/NEJM199602293340902

Thomas DL, Factor SH, Kelen GD, et al.Viral hepatitis in health care personnel at The Johns Hopkins Hospital: the seroprevalence of and risk factors for hepatitis B virus and hepatitis C virus infection. Arch Intern Med 1993; 153:1705-1712.

https://doi.org/10.1001/archinte.1993.00410140095011

Mitsui T, Iwano K, Masuko K, et al. Hepatitis C virus infection in medical personnel after needle-stick accident. Hepatology 1992; 16:1109-1114.

https://doi.org/10.1002/hep.1840160502

Ross RS, Viazov S, Gross T, et al. Transmission of hepatitis C virus from a patient to an anesthesiology assistant to five patients. N Engl J Med 2000; 343:1851-1854.

https://doi.org/10.1056/NEJM200012213432505

Eyster ME, Alter HJ, Aledort LM, et al. Heterosexual co-transmission of hepatitis C virus (HCV) and human immunodeficiency virus (HIV). Ann Intern Med 1991; 115:764-768.

https://doi.org/10.7326/0003-4819-115-10-764

Ohto H. Transmission of hepatitis C virus from mothers to infants. N Engl J Med 1994; 330:744-750.

https://doi.org/10.1056/NEJM199403173301103

Roudot TF. Epidemiological factors affecting the severity of hepatitis C virus-related liver disease: a French survey of 6.664 patients. Hepatol 1997; 26:485-490.

https://doi.org/10.1002/hep.510260233

Amovoso P, Rapicetta M, Tosti ME, et al. Correlation between virus genotype and chronicity rate in acute hepatitis C. J Hepatol 1998; 28:939-944.

https://doi.org/10.1016/S0168-8278(98)80340-1

Villano SA, Vlahov D, Nelson KE, et al. Persistence of viremia and the importance of long-term follow-up after acute hepatitis C infection. Hepatology 1999; 29:908-914.

https://doi.org/10.1002/hep.510290311

Viguier M. B-cell lynphomas involving the skin associ- ated with hepatitis C virus infection. lnt J Dermatol 2002; 41:577-582.

https://doi.org/10.1046/j.1365-4362.2002.01603.x

Agnello V. The etiology and pathophysiology of mixed cryo-globulinemia secondary to hepatitis C virus infection. Springer Semin Immunopathol 1997; 19:111-129.

https://doi.org/10.1007/BF00945029

Levey JM, Bjornsson B, Banner B, et al. Mixed cryoglobulinemia in chronic hepatitis C infection: a clinicopathologic analysis of 1O cases and review of recent literature. Medicine 1994; 73:53-67.

https://doi.org/10.1097/00005792-199401000-00005

Agnello V, Chung RT, Kaplan LM. A role for hepatitis C virus infection in type II cryoglobulinemia. N Engl J Med 1992; 327:1490-1495.

https://doi.org/10.1056/NEJM199211193272104

Bonkovsky HL, Poh-Fitzpatrick M, Pimstone N, et al. Porphyria cutanea tarda, hepatitis C, and HFE gene mutations in North America. Hepatology 1998; 27:1661-1669.

https://doi.org/10.1002/hep.510270627

Lazaro P, Olalquiaga J, Bartolome J. Detection of hepatitis C virus RNA and core protein in keratinocytes from patients with cutaneous lichen planus and chronic hepatitis C. J Invest Dermatol 2002; 119:798-803.

https://doi.org/10.1046/j.1523-1747.2002.00609.x

Olalquiaga J, Hernández I, Sendino R, et al. Infección por virus de la hepatitis C asociada a liquen plano. Estudio epidemiológico sobre una población del centro de España. Actas Dermosifiliogr 1999; 90:295-299.

Mignogna MD, Muzio LI, Favia G, et al. Oral lichen planus and HCV infection: a clinical evaluation of 263 cases. lnt J Dermatol 1998; 37:575-578.

https://doi.org/10.1046/j.1365-4362.1998.00510.x

Carson CW, Conn DL, Czaja AJ, et al. Frequency and significance of antibodies to hepatitis C virus in polyarteritis nodosa. J Rheumatol 1993; 20:304-309.

Kanazawa K, Yaoita H, Murata K, et al. Association of prurigo with hepatitis C virus infection. Arch Dermatol 1995; 131:852-853.

https://doi.org/10.1001/archderm.1995.01690190108029

Cribier B, Santinelli S, Smith C, et al. Should patients with pruritus be tested for hepatitis C virus infection? A case-controlled study. Brit J Dermatol 2000; 142:1249- 1250.

https://doi.org/10.1046/j.1365-2133.2000.03567.x

Darouti ME, Ela ME. Necrolytic acral erythema: a cutaneous marker of viral hepatitis C. Int J Dermatol 1996; 35:252-256.

https://doi.org/10.1111/j.1365-4362.1996.tb02997.x

Kanazawa K, Yaoita H, Tsuda F. Hepatitis C virus infection in patients with urticaria. J Acad Amer Dermatol 1996; 35:195-198.

https://doi.org/10.1016/S0190-9622(96)90322-9

Reichel M, Mauro TM. Urticaria and hepatitis C. Lancet 1990; 336:822-823.

https://doi.org/10.1016/0140-6736(90)93296-2

Cribier BJ, Santinelli F, Schmitt C, et al. Chronic urticaria is non significantly associated with hepatitis C or hepatitis G. Arch Dermatol 1999; 135:1335-1339.

https://doi.org/10.1001/archderm.135.11.1335

García RG, Pérez JL. Manifestaciones dermatológicas en los pacientes con hepatitis C. Piel 2002; 17:51-56.

https://doi.org/10.1016/S0213-9251(02)72537-9

Dumas V, Thieulent N, Sovillet AL, et al. Recurrent erythema multiforme and chronic hepatitis C: efficacy of interferon alpha. Brit J Dermatol 2000; 142:1248- 1249.

https://doi.org/10.1046/j.1365-2133.2000.03566.x

Ural I, Erel A, Ozenirler S, et al. Nodular vasculitis associated with chronic hepatitis C. J Eur Acad Dermatol Venereol 2002; 16:298-299.

https://doi.org/10.1046/j.1468-3083.2002.00487_11.x

Hadziyannis SJ. Skin diseases associated with hepatitis C virus infection. J Eur Acad Venereol 1998; 10:12-21.

https://doi.org/10.1111/j.1468-3083.1998.tb00922.x

Neri S, Racih C, D'Angelo G, et al. Hyde's prurigo nodularis and chronic HCV hepatitis. J Hepatol 1998; 28:161-164.

https://doi.org/10.1016/S0168-8278(98)80216-X

Podanyi B, Lengyel G, Harsing J, et al. Skin diseases associated with chronic hepatitis C. Orv Hetil 1998; 139:2633-2637.

Jackson JM, Callen JP. Scarring alopecia and sclerodermatous changes of the scalp in a patient with hepatitis C infection. J Am Acad Dermatol 1998; 39:824-826.

https://doi.org/10.1016/S0190-9622(98)70357-3